We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Circassia Group Plc | LSE:CIR | London | Ordinary Share | GB00BJVD3B28 | ORD 0.08P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 34.00 | 33.10 | 34.90 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
18/1/2016 15:15 | Shame he doesn't say what price the cat allergy treatment should go at. Rhinitis mention here: "In April 2000, Respiratory Reviews published a study indicating that a patient's out-of-pocket drug costs for treating year-round allergic rhinitis was $1,200. But researcher Timothy J. Sullivan III, MD, of Emory University, calculated that the same patient would pay only $800 for the first year of allergy shots -- the most expensive year. In following years, when allergy shots are done monthly or even less frequently, those costs drop to between $290 and $170. Over six years, that amounts to a $1,300 to $2,900 savings with allergy shots, that study shows." And here for asthma: "less than" $1000 per year for 3-5 years is quoted here: Also, the mention of ragwort failing is confusing. I thought it was ragweed and that's ongoing testing. | hutch_pod | |
16/12/2015 16:56 | Looks like the recent regulatory approval has been received quite well. | hutch_pod | |
28/8/2015 16:35 | Maybe Zak was right? Dipped during the carnage but recovered fast. | hutch_pod | |
06/6/2015 00:15 | Why not buy the target companies with paper? Better for the buyer! | cinques | |
22/5/2015 17:17 | No i'm not either but will hold tight hoping for a break through that will propel these.... | battlebus2 | |
22/5/2015 17:12 | I guess shareholders aren't going to be rushing to take up the open offer... | hutch_pod | |
15/5/2015 15:57 | Is this the start of a multibillion bio company? Wish I could add something more constructive than - 'Woodford seems to think so' :) | hutch_pod | |
10/5/2015 10:32 | Closing in on all time highs now, a great investment so far.. | battlebus2 | |
10/4/2015 11:09 | Another push and £3 :)) | battlebus2 | |
02/4/2015 13:25 | Can't be far from £3 now. | battlebus2 | |
23/3/2015 17:41 | Slowly but surely climbing back to £3. | battlebus2 | |
05/3/2015 20:10 | Aviva and or it's subsidaries increase their holding from 4 to 5%. | battlebus2 | |
02/3/2015 08:42 | Good to see these continue to recover.. | battlebus2 | |
27/2/2015 15:59 | If Woodford likes them then.... | battlebus2 | |
27/2/2015 08:31 | If anyone is interested take a look at the presentation of yesterdays results by downloading it from their website in the section MEDIA. Well worth a look imv, 38 minutes long and shows the potential here. | battlebus2 | |
27/2/2015 08:10 | I'd be a buyer philander, when the cat allergy comes to market the share price will be treble todays imv. | battlebus2 | |
26/2/2015 23:08 | I`ll keep a watch on this one :-) | philanderer | |
26/2/2015 21:33 | Also in the Guardian. | battlebus2 | |
26/2/2015 20:50 | Thanks philander, looks a good bet for 2016. | battlebus2 | |
26/2/2015 20:35 | Evening bb, Questor has just put out a 'buy' on this one. 'Questor share tip: Buy Circassia as cat allergy treatment makes progress' | philanderer |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions